Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Cardiology

  • 1
    News

    DAPA-HF: Dapagliflozin benefits regardless of age, HF severity

    November 25, 2019

    PHILADELPHIA – The SGLT2 inhibitor had similar efficacy in the elderly, and across the spectrum of baseline symptom status.

  • 1
    News

    Large population-based study underscores link between gout, CVD event risk

    November 23, 2019

    ATLANTA – The relationships between gout and fatal and nonfatal CVD events found in a large population-based health data linkage study in New Zealand were not ameliorated by allopurinol use or serum urate lowering to treatment target.

  • News

    Hyperkalemia-related treatment changes linked to death in acute HF

    November 21, 2019

    It’s not the potassium, but the subsequent dosage reduction, that may boost mortality after hospitalization for acute heart failure.

  • 1
    News

    Risk stratification of syncope patients can help determine duration of telemetry monitoring

    November 12, 2019

    In ED patients with syncope, what is the optimal duration of telemetry monitoring to detect underlying arrhythmia?

  • 1
    News

    Better time data from in-hospital resuscitations

    November 11, 2019

    Acquiring accurate time-interval data is “the key to future high-quality research.”

  • 1
    News

    Aspirin for primary prevention reduces risk of CV events, increases bleeding

    November 8, 2019

    What is the association between aspirin for primary prevention and cardiovascular events and bleeding?

  • 1
    News

    Spanish risk score predicts 30-day mortality in acute HF in ED patients

    November 7, 2019

    Is the MEESSI-AHF score valid to use in EDs in Switzerland?

  • 1
    News

    Oral antibiotics as effective as IV for stable endocarditis patients

    November 6, 2019

    Can patients with left-sided endocarditis safely switch from intravenous to oral antibiotics?

  • 1
    News

    New score predicts benefits of prolonged cardiac monitoring for TIA, stroke patients

    November 5, 2019

    How can we determine which patients would benefit from prolonged cardiac monitoring after a neurologic event?

  • 1
    News

    How P-wave indices can improve AFib-related ischemic stroke prediction

    November 1, 2019

    Do the addition of P-wave indices (PWIs) measurements to the CHA2DS2-VASc score improve the ability to predict atrial fibrillation (AFib)–related ischemic stroke?

Previous1 … 40 41 42 43 44 … 79Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences